it should be validated by prospective and independent studies before it can be used in clinical practice.
The majority of this population (95%) were found to be at high or moderate risk for VTE. Prophylaxis was used in only 67% during hospital stay and in 29% after discharge.
Differences in population characteristics preclude direct comparisons between studies, but these findings are similar to those of the ENDORSE study, 5 which found similar VTE risk profiles between countries but major asymmetries in the use of recommended prophylaxis.
The small number of thrombotic events reported in the ARTE study may reflect underdiagnosis. Major bleeding complications occurred in only 3.9% of inpatients under anticoagulant prophylaxis, reflecting the safety of this approach.
More important is the fact that the majority of VTE events occurred after hospital discharge, probably as a result of inadequate prophylactic measures. This finding is consistent with the need for extended VTE prophylaxis, a subject now under investigation, with several studies indicating a potential benefit. 6, 7 Prophylaxis rules were underused in the ARTE study, clearly illustrating the need for dissemination and implementation of guideline protocols. There are various possible ways of improving compliance with guidelines, including the https://doi.org/10.1016/j.repc.2017.10.005 0870-2551/© 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved. 2174-2049 G. Castro use of electronic tools incorporating clinical prediction rules and risk scores. 8 The publication of the ARTE study in the current issue of the Journal is a valuable contribution to extending knowledge of this condition and has the potential to draw attention to the problem of VTE prophylaxis in Portugal.
